Implementation of a Laboratory-Developed Test for the Diagnosis of Mycoplasma pneumoniae Using a High-Throughput Approach

<i>Mycoplasma pneumoniae</i> is a significant causative agent of atypical pneumonia in both children and adults. Timely and accurate diagnosis is crucial for appropriate patient management. Conventional methods for detecting <i>M. pneumoniae</i>, such as culture and serology, exhibit several limitations regarding sensitivity, specificity, and turnaround time. In contrast, real-time PCR is considered the most reliable, rapid, and sensitive technique for the diagnosis of <i>M. pneumoniae</i> infection. In this study, we adapted and validated an in-house real-time PCR assay for use on the fully automated Panther Fusion<sup>®</sup> System. The validation process included two artificial samples, five external quality controls, and sixty-two patient samples. We evaluated the performance in terms of precision, sensitivity, linearity, and analytical sensitivity, comparing it to the original in-house assay. The Panther Fusion<sup>®</sup> System demonstrated a broad dynamic range (16-1.6 × 10<sup>7</sup> copies/reaction), a robust correlation (94%) with the in-house assay, and comparable sensitivity (46 copies/mL vs. 25 copies/mL). The concordance between the in-house real-time PCR and the Panther Fusion<sup>®</sup> System was 100% for both clinical samples and external quality controls. The adaptation of the test to the Panther Fusion<sup>®</sup> System enabled the inclusion of <i>M. pneumoniae</i> among the pathogens monitored for respiratory infection surveillance. Throughout 2024, we analyzed 2567 samples, with a peak positivity rate of 38% observed in August. These findings underscore the significance of employing the <i>M. pneumoniae</i> diagnostic assay on the Panther Fusion<sup>®</sup> System which proves valuable for the detection of <i>M. pneumoniae</i> infections. This platform offers the advantages of increased automation and greater throughput potential compared to other platforms, enhancing the efficiency of respiratory pathogen detection in clinical settings.

Authors

Institutions

Publication Details

Journal
Pathogens
Published
2025-07-14
DOI
https://doi.org/10.3390/pathogens14070692
Citations
1
Primary Topic
Pneumonia and Respiratory Infections
Type
article
Field-Weighted Citation Impact
1.35
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Implementation of a Laboratory-Developed Test for the Diagnosis of Mycoplasma pneumoniae Using a High-Throughput Approach

Valeria Conciatori, Ignazio Castagliuolo, Claudia Del Vecchio, Elisa Franchin et al.
1 citations
Pathogens
Pneumonia and Respiratory Infections
1.35
article

Implementation of a Laboratory-Developed Test for the Diagnosis of Mycoplasma pneumoniae Using a High-Throughput Approach

Valeria Conciatori, Ignazio Castagliuolo, Claudia Del Vecchio, Elisa Franchin, Cristiano Salata, Sarah Di Sopra, Giuseppe Di Pietra, Ioannis Bekas
article en
1 citations

Abstract

<i>Mycoplasma pneumoniae</i> is a significant causative agent of atypical pneumonia in both children and adults. Timely and accurate diagnosis is crucial for appropriate patient management. Conventional methods for detecting <i>M. pneumoniae</i>, such as culture and serology, exhibit several limitations regarding sensitivity, specificity, and turnaround time. In contrast, real-time PCR is considered the most reliable, rapid, and sensitive technique for the diagnosis of <i>M. pneumoniae</i> infection. In this study, we adapted and validated an in-house real-time PCR assay for use on the fully automated Panther Fusion<sup>®</sup> System. The validation process included two artificial samples, five external quality controls, and sixty-two patient samples. We evaluated the performance in terms of precision, sensitivity, linearity, and analytical sensitivity, comparing it to the original in-house assay. The Panther Fusion<sup>®</sup> System demonstrated a broad dynamic range (16-1.6 × 10<sup>7</sup> copies/reaction), a robust correlation (94%) with the in-house assay, and comparable sensitivity (46 copies/mL vs. 25 copies/mL). The concordance between the in-house real-time PCR and the Panther Fusion<sup>®</sup> System was 100% for both clinical samples and external quality controls. The adaptation of the test to the Panther Fusion<sup>®</sup> System enabled the inclusion of <i>M. pneumoniae</i> among the pathogens monitored for respiratory infection surveillance. Throughout 2024, we analyzed 2567 samples, with a peak positivity rate of 38% observed in August. These findings underscore the significance of employing the <i>M. pneumoniae</i> diagnostic assay on the Panther Fusion<sup>®</sup> System which proves valuable for the detection of <i>M. pneumoniae</i> infections. This platform offers the advantages of increased automation and greater throughput potential compared to other platforms, enhancing the efficiency of respiratory pathogen detection in clinical settings.

PathogensVol. 14(7)
University of Padua (IT), Ospedale San Bassiano (IT)
Good health and well-being
Openalex Percentile: Top 18%
Pneumonia and Respiratory Infections
1.35
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.